Skip to main content
logo
NervGen Pharma Corp. (NGEN)
NASDAQ: NGEN · Real-Time Price · USD
1.620
+0.020 (1.25%)
Jul 31, 2026, 4:00 PM EDT - Market closed

NervGen Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1724461531227097
Market Cap Growth
-5.61%190.81%26.05%74.14%-27.73%58.13%
Enterprise Value
1614381381115090
Last Close Price
1.625.602.182.041.192.13

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
33.05175.7785.59-79.937.027.27
P/TBV Ratio
46.76199.21104.44-7.257.48

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.000.04-0.100.02-
Net Debt / Equity Ratio
-2.99-6.34-6.665.71-1.65-1.01
Net Debt / EBITDA Ratio
0.620.880.680.650.971.33
Net Debt / FCF Ratio
0.701.131.021.011.252.05
Quick Ratio
1.091.121.050.792.2015.76
Current Ratio
1.341.161.130.832.2716.16
Return on Equity (ROE)
-1207.45%-1457.57%-8546.24%-390.89%-136.87%-111.94%
Return on Assets (ROA)
-90.75%-73.42%-96.17%-59.88%-68.90%-65.17%
Return on Capital Employed (ROCE)
-479.60%-721.30%-973.90%933.90%-168.60%-76.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-17.39%-7.22%-11.00%-13.94%-21.93%-10.41%
FCF Yield
-9.75%-3.19%-7.64%-7.04%-18.84%-6.77%
Buyback Yield / Dilution
-6.72%-7.44%-13.55%-12.61%-34.00%-22.35%